Macmic Science & Technology Co Operating Expenses
The Total Operating Expenses of Macmic Science & Technology Co (688711.SS) as of Oct 19, 2026 is 138.65 M CNY. In the previous year, Total Operating Expenses was 168.14 M CNY — a change of -17.54% (lower).
Get this data via API
Financial Data API
Operating Expenses
138.65 MCNY
YoY
-17.54%
Last updated:
The Macmic Science & Technology Co Operating Expenses history
3 Years
10 Years
25 Years
Max
| YEAR | Operating Expenses | YoY |
|---|---|---|
| 138.65 MCNY | -17.54% | |
| 168.14 MCNY | -0.99% | |
| 169.83 MCNY | +77.37% | |
| 95.75 MCNY | +70.85% | |
| 56.04 MCNY | +63.07% | |
| 34.36 MCNY | -2.46% | |
| 35.23 MCNY | +8.52% | |
| 32.47 MCNY | +6.68% | |
| 30.43 MCNY | +19.32% | |
| 25.51 MCNY | +14.61% | |
| 22.25 MCNY | +6.41% | |
| 20.91 MCNY | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Macmic Science & Technology Co Stock analysis
Frequently Asked Questions about Macmic Science & Technology Co stock
Total Operating Expenses of Macmic Science & Technology Co is 138.65 M CNY in 2025.
Total Operating Expenses of Macmic Science & Technology Co changed from 168.14 M CNY to 138.65 M CNY, representing a -17.54% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Total Operating Expenses Macmic Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.
Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.
Total Operating Expenses's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Macmic Science & Technology Co historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Macmic Science & Technology Co
All Key Metrics — Macmic Science & Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth